FORMULATION OF TOCILIZUMAB AND METHOD FOR TREATING COVID-19 BY INHALATION
The present invention is directed to formulations containing the anti-IL-6 therapeutic monoclonal antibody tocilizumab and pharmaceutically acceptable excipients that can be administered using a soft mist inhaler or a nebulizer. La présente invention concerne des formulations contenant l'antico...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention is directed to formulations containing the anti-IL-6 therapeutic monoclonal antibody tocilizumab and pharmaceutically acceptable excipients that can be administered using a soft mist inhaler or a nebulizer.
La présente invention concerne des formulations contenant l'anticorps monoclonal thérapeutique anti-IL-6 tocilizumab et des excipients pharmaceutiquement acceptables qui peuvent être administrés à l'aide d'un inhalateur brumisateur ou d'un nébuliseur. |
|---|